PRAZAXA for Atrial fibrillation: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 62 adverse event reports in the FDA FAERS database where PRAZAXA was used for Atrial fibrillation.
Most Reported Side Effects for PRAZAXA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Cerebral infarction | 20 | 12.5% | 1 | 7 |
| Embolic stroke | 12 | 7.5% | 1 | 7 |
| Drug ineffective | 10 | 6.3% | 2 | 6 |
| Cardiac failure | 9 | 5.6% | 0 | 4 |
| Activated partial thromboplastin time prolonged | 8 | 5.0% | 0 | 5 |
| Interstitial lung disease | 8 | 5.0% | 2 | 6 |
| Cardiac failure chronic | 6 | 3.8% | 2 | 5 |
| Fall | 6 | 3.8% | 1 | 5 |
| Death | 5 | 3.1% | 5 | 1 |
| Renal impairment | 5 | 3.1% | 0 | 3 |
Other Indications for PRAZAXA
Other Drugs Used for Atrial fibrillation
RIVAROXABAN (52,584)
DABIGATRAN ETEXILATE (20,492)
APIXABAN (10,500)
AMIODARONE (9,083)
WARFARIN (8,680)
EDOXABAN (3,855)
ASPIRIN (2,993)
DOFETILIDE (2,439)
PRADAXA (2,325)
METOPROLOL (1,542)